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A B S T R A C T
Citrus aurantifolia (Christm.) Swingle (syn. C. MEDICA var. ACIDA Brandis) (family: Rutaceae) essential oil is one
of the cheapest oils found in local markets. Although, it is generally accepted as non-toxic to vital organs and
cells, majority of people are cynical about it usage. Herein, the present study reports the chemical composition
and in vivo oral toxicity study of unripe C. aurantifolia essential oil found in Ghana. The toxicity of C. aurantifolia
essential oil extract was investigated via oral administration using two methods: The acute toxicity single dose
study (SDS) and the repeated dose method. The oil exhibited no acute toxicity but in the sub-chronic studies, the
effects was dose and time-dependent. Chemical profile investigation of the oil showed 9 constituent of phyto-
chemicals (Germacrene isomers (61.2%), Pineen (14%), Linalool dimmer (2.9%), Bornane (11%), Citral (2.9%),
Anethole (1.5%), Anisole (1.1%), Safrole (0.3%) and Demitol (0.6%)). Histopathological studies revealed con-
ditions such as necrosis, edema and inflammatory reaction in the liver, spleen and kidneys. Marginal upsurge of
biochemical parameters above normal and elevated levels of lymphocytes (35.20–46.40 g/dL) demonstrated
mild toxicity among the 100mg/kg and 500mg/kg dose groups at the sub-chronic stage. Low levels of he-
moglobin (13.60 to 12.70 g/dL), MCV (34.20–24.0 fL), MCH (40.20–36.40 g/dL) along with high levels of liver
enzymes confirmed the mild toxicity of the oil at sub-chronic stage. These results demonstrate that, despite
consideration of lime essential oil as safe, it can have mild hematotoxic, nephrotoxic and hepatotoxic effects.
1. Introduction
The Search for medicinal plants and their phytochemicals as alter-
native for treating various diseases has generated interest among re-
searchers. Although, C. aurantifolia’s (Lime) exact lineage is doubtful,
the perception is that it was grown first in Indonesia or Southeast Asia,
before transported to the Mediterranean Region and Northern Africa
around 1000 CE [1]. In Ghana and other West Africa countries, lime
fruits and its juice is a major medicinal recipe for local folks. The juice
in combination with neem leaves extract has been used for managing
malaria, diabetes, and other parasitic diseases [2]. Locally, it is a major
anti-deodorant agent, and also added to local gin (“Akpeteshie”) for
taste as well as masking of odour of the “Akpeteshie”. The lime juice
mixed with other plant extract has been a major remedy for boil control
locally. The root back is a good febrifuge. Decoction of the bark is a
major remedy for gonorrhoea and related disorders. In Nigeria, the
roots of the plant are chewed for headache, and eaten as a vermifuge.
The leave is use as a lotion for fever and eye disease [2]. The other
component of lime fruit which has not been utilized and ignored locally
is its essential oil. Steam distillation and cold pressing are two main
methods used to extract Lime (Citrus aurantifolia) essential oil mainly
from the fruit rind. A study on aromatic volatiles in key lime oil has
revealed that the freshnes and citrus aroma is as result of its major
constituents such as: geranial, neural, and linalool [1]. These con-
stituents are attributable to the immense properties (astringent, tonic,
antiseptic, antiviral, antimicrobial, restorative, stimulant) of the oil [1].
Above all, they are also responsible for the health-promoting attributes
[3–7]. In small doses, lime essential oil is known to serve as an appe-
tizer and to increase one’s appetite when smelled [8]. In certain parts of
Ghana, people smear the essential oil of lime on their skin to prevent
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mosquito bites, and some add it to their drinking water for enhanced
flavour and as antioxidants [9]. One of the major uses of essential oil is
aromatherapy. This treatment regimen could be used to induce re-
laxation, but there is lack of information or evidence to prove essential
oils effectivness in treating this condition [10]. Improper use of es-
sential oils may cause harm, including allergic reactions and skin irri-
tation which are some of the side effects from improper use of the lime
essential. Children in particular may be the most affected group via
improper use of the oil [11]. D-limonene is among the major compo-
nents of lime essential oil which has been reported to have certain ef-
fects on the lungs at certain concentrations [12]. One typical example,
is the pumonary exposure of human volunteers to d-limonene which
caused a decrease in the lung vital capacity at highest doses [13]. Re-
search has established that renal problems caused by essential oil in
humans are rare and if it should occur, it is usually associated with oral
overdose in acute dosing [14]. Much have been established concerning
adverse effects of volatile organic compounds (VOCs) including essen-
tial oil constituents on the lungs and other tissues [14]. If exposure is
high enough, VOCs can cause sensory irritation of the airways char-
acterized by irritation, tickling, burning, cooling, warming and stinging
in the nasal cavities. Bronchial hyperactivity (BHR) is also an adverse
effect associated with exposure to VOCs [15]. Long term exposure to
moderate concentrations of mixtures of terpenes (an essential oil con-
stituent) entails possible health risk [14].
Generally, lime essential oil is acknowledged as safe (GRAS) when
used as a food additive and food flavouring agent by an American Food
and Drug Administration (FDA) [16]. To the best of our knowledge,
however, no published repeated dose toxicity study is available on the
oral use of lime essential oil as medication or dietary supplement. In-
formation on toxicity of lime essential oils when used as drug or dietary
supplements is therefore scanty [16]. Additionally, not much is known
about the toxic effects of the lime essential oil found in Ghana, but the
originator of toxicology, Paracelsus, professed that “all substances are
poisons; there is none which is not a poison, the right dose differentiates
a poison from a remedy” [17,18]. This statement makes it imperative to
investigate the toxicity of lime essential oil of the unripe fruits, since the
unripe oil has been effective in treating several diseases locally. As
several essential oils are considered “GRAS”, yet most essential oils
have not been studied, especially, in concentrated internal amounts for
which lime essential oil is one [19]. Ecologically, there has been few
complains of pains of the heart when oil is added in drinking water.
Also, burning sensation when the oil was massaged onto the skin have
been reported by the users. Taking into account the rampant use of the
oil all over the world, especially, Ghanaians and the fact that tox-
icological data lacking, we aimed to evaluate the acute, sub-acute and
sub-chronic toxicity of the unripe oil extracted from slurry of entire
lime fruit. Thus far, no documented toxicological assessments of unripe
lime essential oil in which mainly monoterpenes are present. However,
no documented fact regarding toxicity of unripe lime essential oil was
found in literature. Unlike the ripe oil, the impact of unripe essential oil
toxicity may be greatly be affected either positively or negatively, due
to its chemical complexity. This is because, unripe lime essential oil has
been found to comprise a greater number of metabolites compare to rip
oil. Traditionally, the ripe oil is the most utilized oil. Preliminary in-
vestigation of unripe lime essential oil has demonstrated several po-
tential therapeutic efficacy superior to the ripe oil. Such therapeutic
efficacies are: anti-oxidant, anti-inflammatory, anti-bacterial, anti-
fungal, anti-diabetic, anti-leishmanial as well as wound healing. Hy-
pothetically, the unripe oil is expected to have no detrimental effect on
vital organs.
Aim of The Study
The main intent of the present work was to investigate in vivo
toxicity profile of unripe essential oil.
2. Methodology
2.1. Chemicals and materials
Reagents and Chemicals: absolute alcohol, xylene, paraffin wax,
formaldehyde and eosin were acquired from Sigma Aldrich and used
without further purification. Lime essential oil was extracted via steam
distillation method under standard laboratory conditions following
method reported in literature with slight modifications [20].
2.2. Citrus aurantifolia and extraction of unripe lime essential oil (LEO)
The unripe fruits of Citrus aurantifolia was collected from a small
town called Amissakrom Ekroful in the Mfantseman District, Central
Region, Ghana, with voucher specimen number CCG-4615. The fruit
was identified by a Botanist (Mr Ogoe) at the School of Biological
Sciences herbarium. The fruits were washed and cut into two parts,
milled with a cutting mill (TECNAL, type Willye TE650) to particles size
of 2.0 mm. [21]. The slurry material was then stored at room tem-
perature (25 °C) with humidity (60%) in drum and subsequently, dis-
tilled at 80 °C [22]. Anhydrous sodium sulfate (Merck, Germany) was
added to the extracted LEO untill free movement of anhydrous solid,
filtered and dried LEO stored at room temperature for GC and GC/MS
analysis.
2.3. Gas chromatography mass spectrometry (GC/MS) elucidation of
unripe lime essential oil chemical constituents
The essential oils were analyzed using GC/MS (Shimadzu capillary
GC-quadrupole MS system QP 5050A) with a fused silica capillary
column DB-5 (30m, 0.25mm i.d, film thickness 0.25 μm). The injector
and detector temperature was set at 250 °C. The essential oil dissolved
in methanol was injected at initially column temparature (80 °C) for
3min. The system temparature was increased up to 275 °C (5 °C/min).
Carrier gas used was Helium (1.56ml/min). The comparative quantity
of total individual constituents of the LEO was presented as percentage
peak area relative to the total peak area. Qualitative identification of
the different constituents was performed via comparing relative reten-
tion times with standards values. Mass spectra of individual compo-
nents were also compared with authentic reference compounds, or by
retention indices (RI).
2.4. Animal
Total of 40 Sprague Dawley rats of approximately 8 weeks old and
of weights between 70 and 230 g were used for the study. The Sprague
Dawley rats of both sex were purchased from Noguchi Memorial
Institute for Medical Research, University of Ghana, Accra and kept at
the Animal House Facility of the Department of Biomedical Sciences,
UCC, Cape Coast, Ghana. The females were nulliparous as well as non-
pregnant and were separated from males prior to the experiment. The
animals were permitted to accustom in the laboratory for 7 days. They
were accommodated in polystyrene cages in which the floor was
shielded with sawdust to lessen the likelihood of painful contact with a
rigid surface. The animals were retained in 12 h light-dark sequence
with full access to food and water. The feed was purchased from GAFCO
Trading Company, Tema. Also the animals were permitted to famil-
iarize to the animal house condition (Temperature 24–25 °C, relative
humidity 60–70%). All ethical clearance in animal’s management as
defined in the US National was observed. The entire animal experi-
mentation, procedures, and techniques employed in this study were
done in accordance with the National Institute of Health Quidelines for
care and use of laboratory animals [23].
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2.5. Maintenance and acclimatization of animal
One week acclimatization period was allowed after receiving the
animals. Rats were quarantined in a room for this one week acclima-
tization period while daily clinical examination ensued. Only clinical
healthy rats were employed for clinical examination. The rats were
housed in aluminum cages (12.5×16×7.5 in.) with softwood shav-
ings as bedding and kept in animal rooms at the laboratory. Animals
were fed on food and water ad libitum. The test sample was adminis-
tered by mouth using the oral gavage method and permanent board
marker used to denote the rats.
2.6. Ethical approval for animal studies
The study was given ethical clearance approval by the Ethical
Committee on Animals of the Department of Biomedical Sciences,
School of Allied Health Sciences, University of Cape Coast, Cape Coast,
Ghana in accordance with the Guide for Care and Use of Laboratory
Animals, NIH, Department of Health Services Publication, USA, no. 83-
23, revised 1985 [24].
2.6.1. Experimental design
The forty rats were used to determine the toxicity of lime essential
oil. A day before the test, rats were weighed and grouped into four. The
allowed weight variation among the animals in each group was 20%.
Since no adverse effects were expected at the doses 50mg/kg bw/d,
100mg/kg and 500mg/kg, controlled test was performed to analyse
the repeated exposure dose in rats for 24 h, 28 and 60 days, respec-
tively, following the guidelines 423 and 407 of the Organization for the
Economic Cooperation and Development [25]. These doses were chosen
for this work since no adverse effects were recorded following an akin
procedure by Nǵuni et al. (2018) [26]. Calculated doses of the essential
oil (base on the acute toxicity studies using graded concentrations of
test substance via method developed by Chinedu et al. (See supple-
mentary document)) [27] were orally administered to the animals as
follows: Group 1, designated as low dose (50mg/kg), Group 2: labeled
as medium dose (100mg/kg) and high dose (500mg/kg) as group 3,
with Group 4 serving as normal control. The total number of animals in
each group was ten (10).
2.6.2. Preparation of essential lime oil solutions
Solutions of essential oil (50, 100 and 500mg/kg) determined from
the acute toxicity study (See supplementary document) were prepared
by weighing appropriate volumes of the lime essential oil. It was then
dissolved in required volumes of water to obtain the needed con-
centrations for each treatment groups. Since oil is immiscible with
water, the oil was first dissolved in 0.1% Tween 20 a surfactant, fol-
lowed by dissolution in water at ratio 1.14: 9.09: 89.00mL of oil,
Tween 20 and water respectively.
2.7. Administration of oil
Two different types of toxicity studies were conducted on the ex-
perimental rats namely the single dose study (SDS), which involves the
effect of a single dose in the experimental rats. Here, rats were mon-
itored at hourly intervals to observe behavior changes and toxicity.
These signs normally present themselves in the form of apnea, dyspnea,
salivation, convulsion, changes in motor activity and so on and was
observed for 24 h. The repeated dose studies involve long duration
studies of daily feeding, monitoring of toxicity and physiological
changes. The rats in the control group were also given the same treat-
ment except that they were given water for the duration of the ex-
periment. After observing for 28 days for sub-acute and 60 days for sub-
chronic studies, the rats were sacrificed and blood dispensed into
chemistry tubes and Ethylenediaminetetraacetic acid (EDTA) tubes for
biochemical and hematological indices analyses respectively. These
animals were euthanized and dissected, and the spleen, liver, lungs, and
kidneys collected, preserved in formalin and processed. The last phase
of the study which was the sub-chronic phase ended on the sixtieth day
and was carried out in the same way as the sub-acute phase.
2.8. Hematological and biochemical analysis
Experimental rats blood were analyzed for hematological and bio-
chemical parameters following procedure reported in literature [28].
Hematological indices: red blood cells (RBCs), hemoglobin (Hb), he-
matocrit (HCT), mean corpuscular volume (MCV), mean corpuscular
hemoglobin (MCH), mean corpuscular, hemoglobin concentration
(MCHC), monocytes (MON) neutrophils (NEU), and lymphocytes (LYM)
were ascertained via an automated hematological analyzer. The blood
serum was sampled into an empty vacutainer tubes after 5min cen-
trifuged of the whole blood. The serum was analyzed for biochemical
parameters: Alanine aminotransferase (ATL), aspartate amino-
transferase (AST), alkaline phosphatase (ALP) total bilirubin (TB), total
protein (TP), total cholesterol (TC) triglycerides, high density lipopro-
tein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C)
and very low-density lipoprotein cholesterol (VLDL-C) using assay kits.
2.8.1. Biochemistry analysis
Chemistry analyzers are employed to analyze the amount of certain
metabolites, electrolytes, proteins, and drugs in samples of serum,
plasma, urine, cerebrospinal fluid, and other body fluids [28]. In this
study, the serum samples were loaded onto a tray and the test was
programmed through barcode scanner. Reagents were already stored in
the analyzer. The barcode scanner was used to read the test orders of
the label on each test tube. Reagents were distributed into the reaction
vessel after which the solution was mixed and passed through a ca-
lorimeter to measured its absorbance while it was still in its reaction
vessel. Chemical concentrations were then computed and recorded ac-
cordingly.
2.8.2. Hematology analysis
The Abbot Hematology analyzer (SK 8800 Class II) was used to
perform this test [29,30]. Samples were placed in a single file by hy-
drodynamic focusing and laminar flow and cells streamed through a
flow cell for purposes of counting and analysis. White blood cells were
counted and categorized by laser light-scattering data, via a multi-angle
polarized scatter with separation technique. The angle of scattering as a
function of cell size, refractive index nuclear shape, nuclear-cyto-
plasmic ratio, and granularity. Optical scatter and fluorescence tech-
nology with an argon laser were also used to count red blood cells and
to separate differential leukocyte count parameters.
2.9. Histological analysis
Histological analysis was performed following literature method
[31]. Firstly, the tissue went through tissue cut up where it was cut into
smaller pieces to fit the tissue cassettes and into formalin. The tissue
sections were set into an automated tissue processing machine (Leica
TP 1020) to start the tissue processing. This consisted of four stages,
continuous fixation with formalin to preserve the physical structure of
the tissue and to prevent postmortem changes. Dehydration with
graded alcohol, that is, from 75% to 100% (absolute) to remove all the
water from the tissue and to allow tissue infiltration by nonpolar sol-
vents were done. Clearing of alcohol from the tissue with xylene and
infiltration with paraffin wax was the last stage of the tissue processing
stage after which tissue embedding was carried out.
2.9.1. Tissue embedding
In this step, metallic molds were used together with molten wax to
mold the tissue into blocks using the embedding center (Leica EG
110H). The tissue blocks were then refrigerated to harden them after
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which microtomy was carried out. Tissue blocks were cut into thin
slices using the microtome machine (Leica RM 2125 RT). The sections
were cut at 5 microns, floated on a floating bath (Thermos Scientific
MH 8516×6) at a temperature 10% below that of the paraffin wax
(56 °C) and picked with the aid of microscope slide. The slides were
then dried in hot air oven (Thermos scientific model 652) overnight.
2.9.2. Staining
After drying, the tissues were stained in the staining machine (Leica
ST 4040) which contained three changes of xylene and several changes
of alcohol. The slides of tissue were allowed to pass through the xylene
and alcohol. The slides were then stained with hematoxylin for 10 to
15min to stain the nuclei purple. They were then stained with eosin for
60 s to stain the cytoplasmic components pink. Afterward, the slides
were passed through graded alcohol to take out excess water from the
stained tissue.
2.9.3. Mounting
The tissue sections were mounted using DPX mountant and covered
with coverslips, and subsequently examined under the microscope.
Lastly, histopathological examination of the microscopic architecture of
the tissues was examined on the H & E slides. Quantitative grading
criteria; nil (0–5), mild (> 5-24), moderate (> 24-50) and severe
(> 50), were used to quantify the pathological lesions identified in the
histological sections.
2.10. Statistical analysis
Data analysis was done via SPSS version 21.0. Data were depicted as
mean ± SEM online graphs and tables. One-way-ANOVA test was
employed to analyze the deviations in toxicities of different groups of
animals. To compare control and treatment groups, independent sam-
ples t-test for the significance of difference were used. These were done
with an alpha level of 0.05.
3. Results and discussion
3.1. Chemical composition of the unripe lime essential oil
Exploiting the single ion monitoring (SIM) chromatograms created
via accurate m/z representing terpenes as reported in literature [32,33],
respective MS spectra of components of the essential oil were generated
and the molecular formulae computed base on foundation that the
isotopic fit ratios (iFit) was close to zero (Table 1). GC/MS analysis of
unripe lime essential oil identified ten (10) phytochemicals as con-
stituents (Fig. 1). Of these, two Germacrene isomers were the major
components (61.2%) followed by Pineen (14%) and Bornane (11%)
respectively. The rest of the components were traces as follows: Linalool
dimmer (2.9%), Anisole (1.1%), Anethole (1.5%), Safrole (0.3%), Citral
(2.9) and 2,6-dimethylheptan-2-ol (Demitol) (0.6%) (Table 1). Other
chemical constituents were in small indefinite quantity. Table 1 re-
present the retention times of the major components. For example, the
component labeled as 9 in the GC spectrum with m/z 152 was identified
to be citral with a typical fragmentation pattern of this compound de-
picted in the MS spectra in Fig. 1 comparable to literature data [32,33].
The characteristics of the detected compounds were further searched
and confirmed by the Dictionary of Natural Products online database
(dnp.chemnetbase.com/) as well as comparison with other published
data. The molecules were positively identified via individual molecular
fragmentation patterns (Fig. 1, Scheme S1-5). Based on the MS frag-
mentation patterns, various terpenes components were tentatively
identified listed in Table 1. (Fig. 1 & Figure S3). Accordingly, molecules
2, 3 and 4 (Fig. 1, Figure S1-3, Table 1) were identified as the isomers
of germacrene and dimmer of linalool respectively. For instance, mo-
lecule 1 at retention time (Rt) of 5.05min. (Fig. 1) showed a precursor
ion at m/z 136 [M+H] (C10H16) and chemical break down of this
molecule (Fig. 1, Scheme 1) resulted in molecular ion of m/z 121. This
is predicted to be loss of methyl (−15Da) moeity after a possible 1,2
methyl rearrangement of dimethyl derivative of pinene to a more stable
derivative of β-pinene (Scheme 1) [33]. Products ions at m/z 93 cor-
responds to the loss of propenyl group (forty-three mass units (−43 Da)
was also observed to be the bass peak with 100%. The component is
tentatively recorded as β-pinene since the abundance of ion M/e=41
is more than half of the base peak whilst that for the α-isomer is always
less than one-quarter [33,34]. This molecule (m/z 136) is also dis-
tinguished from other isomers such as limonene which has it base peak
at m/z 68 [34,35]. Based on respective building blocks fragmentation
patterns, molecules 1-10 were positively identified and characterized
similarly as presented in supplementary documents section (Figure
S1–5, Scheme 1–5).
3.2. Animal studies
3.2.1. General status, behaviour and clinical symptoms
Throughout the study (60 days), the rats were examined for clinical
symptoms or signs of toxicity on a daily basis. Alterations of skin and
fur, mucous membranes, eyes, circulation, breadth, functions of the
nervous system, salivation, diarrhea, and convulsions were some of the
signs that were checked for acute toxicity but none of these were ob-
served. However, two weeks into the test, a reduction in the appetite of
the experimental animals was observed and this continued until the end
of the 60 days, even though lime oil from different locations in the
world have been used as appetizer. The reason could the source of the
oil, thus, from unripe fruit and also location. Four cases of mortality
were recorded during the study and these deaths were attributed to
damaging effects of the experimentally induced disease condition cre-
ated or aspirates which may have flooded the blood-air barrier due to
oral gavaging process. The weights measured in four weeks (Table S2
Supplementary documents) were used to draw statistical inferences on
the effects of the oil on weight. No significant variation observed
Table 1
Percentage composition and retention time of chemical composition of unripe lime essential oil.
Peak No. Components Formulae Measured (m/z)[M+H]+ Calculated
(m/z)[M+H]+
Relative % Retention Time (min)
1 Pinene C10H16 136 136 14.3 5.05
2 Germacrene C15H26 207 207 49.0 6.08
3 Germacrene isomer C15H26 207 207 12.2 6.79
4 Dimer linalool 2(C10H18O) 309 309 2.9 7.52
5 Anisole C7H8O 110 110 1.1 9.64
6 Bornane C10H18 139 139 11.3 10.32
7 Anethole C10H12O 148 148 1.5 11.67
8 Citral/Geranial C10H16O 152 152 2.9 12.48
9 Safrole C10H10O2 161 161 0.3 14.48
10 Damitole C9H20O 145 145 0.6 15.04
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between the groups’ weights under study since F critical was higher
than or equal to F (Table S3). This means ingestion of the oil had no
significant consequence on the weight. From the graph (Fig. 2, Table S2
supplementary document), the transient reduction in weight was
observed in all the groups including the control, confirming that the
reduction in weight in the low, medium and high dose groups was not
as a result of test sample oil.
3.3. Histopathological evaluation
3.3.1. Liver
Microscopic analysis of the control group liver revealed tissue sec-
tions with normal histological structure. The parenchymal cells of the
liver, hepatocytes, were tightly packed and were polygonal in shape
[36]. Hepatic sinusoids, lined by endothelial cells, radiates from the
central vein towards the periphery of the lobules (Fig. 3A). In the sub-
acute stage, liver sections from the low dose (Fig. 3B) group showed
normal cytoarchitecture with few pyknotic nuclei. This may be attrib-
uted to some constituents of the oil, germacrene D and linalool, which
are known to have cytotoxic activity towards a wide range of cell lines
[37,38]. Histological section from the group that had the medium dose
(Fig. 3C) revealed mild signs of sinusoidal dilatation, edema and leu-
kocytosis. For the high dose (Fig. 3D), section revealed congestion of
Fig. 1. GC/MS of unripe lime essential oil showing MS fragment of pinene.
Scheme 1. Fragmentation pattern of beta pinene.
Fig. 2. A graph of mean weights (g) against weeks for the control, low, medium
and high dose groups.
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the central vein, distortion of the tissue structure and leukocytic in-
filtrates. Hepatocytes of both groups (medium and high dose), however
were devoid of pyknotic nuclei.
Despite the popular belief that the oil has anti-inflammatory prop-
erties, signs of inflammation were seen again in the tissue sections of all
the dose groups at the sub-chronic stage of the study with the high dose
group (Fig. 3G), showing the most severe pathological changes (dilation
of sinusoids, severe Kupffer cell activation and congestion within si-
nusoids and central vein). The low dose group (Fig. 3E) also showed
leukocyte infiltration which normally indicates that an infectious or
toxic agent is present while the medium dose group (Fig. 3F) showed
congestion of the central vein along with a few pyknotic nuclei. The
severity of the pathological changes observed seemed to be time and
dose dependent. For example, edema and mild leukocytosis are seen in
the medium dose group at the sub-acute stage with the high dose group
showing congestion, distortion of tissue architecture and mild leuko-
cytosis. Also, mild leukocytic infiltration was observed in the sub-acute
stage of the high dose group as opposed to the severe Kupffer cell ac-
tivation seen in the same high dose group in the sub-chronic stage. This
was corroborated by a study on trans-anethole (a constituent of lime
essential oil) using rats as models where dose-related hepatic cell
edema and degeneration were observed [39]. However, extracts and
oils of the citrus family has been reported to be hepatoprotective in
multiple studies [40,41]. Thus, from observed results, tolerable dose
will be ideal for use.
3.3.2. Kidney
Photomicrographs of the kidney sections of the control and treated
groups are presented in Fig. 4A-G. Histological section of the normal
control group (Fig. 4A), showed normal renal architecture; intact re-
presentative renal corpuscles (Bowman capsule plus glomerulus), cap-
sular space and surrounding proximal (PCT) and distal convoluted tu-
bules (DCT). The low dose (Fig. 4B) had normal renal architecture as
compared to the normal control group.
However, cases of necrosis were observed in the kidney sections for
the medium and high doses (Fig. 4C and D), suggesting the presence of
a toxic agent. The medium dose group (Fig. 4C) shows signs of edema
and hydropic changes, with the high dose, revealing oedema and ne-
crotizing lesions with the glomerulus, accompanied by distortion of
tubules (DCT and PCT), are indicative of tissue damage.
In a previous study by Sun (2007), using experimental rats, d-li-
monene, microscopic evidence of compound-related nephropathy was
noted. Beta pinene and D-limonene are group of organic compounds
demonstrated to stimulate a unique nephropathy syndrome in rats after
sub-acute or sub-chronic exposure [42,43]. This could account for the
pathological lesions observed in Fig. 4C and D. Again, the pathological
insults produced by the oil seem to be more severe as the dosage of the
oil increases. The histological changes observed in the tissue sections at
the sub-acute stage were also seen in the sub-chronic stage, but more
severe in the latter (Fig. 4E-G), confirming the suspicion that the effect
of the oil is dose and time-dependent. This assertion is again supported
Fig. 3. Photomicrographs of liver sections for
the normal control (A), sub-acute (B–D) and
sub-chronic (E–G) stage. (A) Control group:
shows hepatocytes with normal cytoarchi-
tecture devoid of injuries. (B) Low dose: shows
very few pyknotic nuclei (blue arrow) of he-
patocytes. (C) Medium dose: shows sinusoidal
dilatation accompanied by mild oedema (black
arrows), with very mild leukocytosis. (D) High
dose: shows congestion (CN) within the central
vein along with distortion of architecture of
the tissue (black arrow) and mild leukocytosis.
(E) Low dose: shows marked leukocyte in-
filtration (arrow heads). (F) Medium dose: CN
of central vein and focal pyknotic nuclei (black
arrows) present. (G) High dose: mild dilation of
sinusoids, severe Kupffer cell activation (blue
arrows) and CN within sinusoids and central
vein (H & E×100).
Fig. 4. Photomicrographs of kidney sections
for the normal control (A), sub-acute (B–D) and
sub-chronic (E–G) stage. (A) Control: normal
glomeruli (Gl) and tubules showing no injuries.
(B) Low dose: shows normal histology of Gl
(blue arrows) as compared to the normal
group. (C) Medium dose: shows oedema (white
asterisks) and hydropic changes (hc). (D) High
dose: shows oedema (asterisks) and Gl necrosis
(blue arrows). Also, distortion of Gl structure
and the tubules, are indicative of tissue da-
mage (E) Low dose: Normal histology as com-
pared to the normal group, with presence of
congested vessels (black arrow). (F) Medium
dose: marked glomerular necrosis (black ar-
rows) and oedema (blue asterisk) marked by
dilation of the tubules. (G) High dose: shows
few pyknotic cells (black arrow) of PCT and
DCT, increased Bowman’s space (blue arrow
head) caused by Gl atrophy and necrosis (blue
arrow) (H & E×100).
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by a study on carvacrol and rosemary essential oils where it was stated
that natural essential oils manifest cytotoxic effects on living cells de-
pending on their type and concentration [44], which means the higher
the dosage of the oil given, the more severe the cytotoxic effects eli-
cited. Similarly, higher doses of essential oils from other plants else-
where, has been reported to have nephrotoxic effect [45]. Our ob-
servation does not aggree with report by Deshmukh et al. (2017), who
demonstrated that bitter orange (Citrus aurantium L.) extract of stan-
dardized 50% p-synephrine, demonstrated non-adverse effects after
treating rat with 1000mg/kg body weight/day [46]. However, it pre-
supposes that, toxicity of Citrus aurantium extract from this study is
primarily due to it’s chemical constituents with Germacrene (61.2%) as
major costituent.
3.3.3. Spleen
The tissue sections of the control group spleen (Fig. 5A) also showed
normal cells with dense irregular collagenous connective tissue capsule
covering, around the parenchyma of the dark red organ [36]. Accu-
mulation of hemosiderin in the spleen in the low dose group in both the
sub-acute (Fig. 5B) and sub-chronic (Fig. 5E) stages of the study sug-
gests the destruction of defective or damaged red blood cells, as pre-
viously reported by other studies [47,48]. This could also be attributed
to the cytotoxic effect of the major constituent of the LEO germacrene D
[37].
A review on the biological effects of essential oils also indicated that
essential oils could act as pro-oxidants in eukaryotic cells, and produce
a cytotoxic effect on living cells instead of antioxidants which protect
cells [49]. It is, however, unclear why this was not observed in the
medium and high dose groups. Instead, the medium and high dose
groups showed dilation of sinusoids which suggests inflammation
leading to distortion of reticuloendothelial cells and cytoarchitecture
for both the sub-acute and sub-chronic stages of the experiment (Fig. 5F
and G).
3.3.4. Lungs
Examination of control group tissue sections revealed normal his-
tological architecture of lungs with the presence of alveolar ducts
leading into alveolar sacs (Fig. 6A). The oil does not seem to have much
effect on the cellular architecture of the lungs of the experimental rats
(Fig. 6B-G). However, very mild influx of inflammatory cells and vas-
cular congestion are seen in the sections. During inflammation in the
lungs, the epithelial cells contrived mediators like: reactive oxygen
radicals, cytokines (TNF-α, IL-1β, granulocyte / macrophage colony-
stimulating factor [GM-CSF]), and platelet-activating factor to assemble
inflammatory cells to the site of inflammation [50]. This requires a lot
of blood to be directed to the site of inflammation which could have led
to vascular congestion. The pathological conditions seen in the tissue
sections in both stages of the experiment do not seem to be severe
enough to classify the oil as toxic to the lungs when ingested orally. The
higher dose group of the sub-chronic stage (Fig. 6G), nevertheless,
showed focal areas of marked leukocytic infiltrates. And this is sup-
ported by the significantly (p < 0.001) high leukocyte count observed
in this group.
A study conducted on the dermal toxicity of linalool, another con-
stituent of lime essential oil, and its esters, yielded some results that
could further help to understand the effects observed in the tissues.
Linalool was applied to the skin of Wistar rats at dose levels of 125, 250,
500, 1000, 2000 and 4000mg/kg/day for 29 consecutive days as a
range-finding study for a 90-day study [51]. In the aforementioned
study, some of the histopathological changes observed were erythema
and edema which are signs of inflammation. This means linalool could
also have contributed to the inflammatory reaction seen in the liver,
kidney, and lungs.
3.4. Serum biochemical parameters
From Table 2, it was observed that when the lime essential oil was
administered to the rats for sub-acute period, slight decrease in the total
cholesterol levels except for the HDL which appears to have increased
significantly among the low to medium dose group rats. The increase in
the HDL levels might be the reason for the decrease levels of total
cholesterol. When the lime essential oil’s dose was increased (among
the high dose group rats), substantial increment of the total cholesterol
levels was discovered except LDL and VLDL levels which reduced
drastically relative to control group at both sub-acute stages (Table 2).
Drastic reduction in HDL levels will mean less cholesterol is transported
for metabolism by the liver. Hence, more cholesterol will be present in
the blood [52,53]. In Table 2, it is also observed that the liver enzymes
namely AST and ALT increased in all the various dose groups ad-
ministered rats in the sub-acute stage as compared to the normal con-
trol. This result might indicate injury to the liver. This is because ALT is
more specific for hepatic injury since it is found mainly in the hepa-
tocytes. Comparing the liver enzyme data among low and medium dose
groups with the high dose group, high dose resulted in an increased
levels of the liver enzymes. This could be as a result of the mild de-
rangements impacted on the hepatocytes in this group. In addition, the
amount of conjugated bilirubin increased and that of unconjugated
bilirubin decreased in all the groups relative to the normal control. The
high levels of the conjugated bilirubin might be as a result of increased
levels of liver enzymes within the liver cells that process the bilirubin.
Fig. 5. Photomicrographs of spleen sections for
the normal control (A), sub-acute (B–D) and
sub-chronic (E–G) stage. (A) Control: normal
tissue with the red and white pulps and the
marginal zone separating them (B) Low dose:
shows accumulation of hemosiderin (blue ar-
rows) within the reticuloendothelial cells (blue
arrows). (C) Medium dose: shows venous con-
gestion (CN) with a little tissue distortion as
compared to the control and low dose groups.
(D) High dose: distortion of reticuloendothelial
tissue and cytoarchitecture (black arrows) of
spleen and atrophy of cells with marked spaces
between adjacent immune cells. (E) Low dose:
deposition of hemosiderin in the re-
ticuloendothelial tissues. (F) Medium dose:
shows sinusoidal dilatation and oedema (black
arrows). (G) High dose: shows sinusoidal dila-
tation evident as oedema (black arrows), more
severe than what is observed in the medium
dose group (H & E×40).
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This could also be due to hepatocytic cell damage seen in the histolo-
gical analysis, affecting liver function. These may facilitate bilirubin
spill into the blood stream [54]. Comparing levels of bilirubin recorded
in the low and medium dose groups to those recorded in the high dose,
the high dose group had higher levels of conjugated bilirubin and very
low levels of unconjugated bilirubin.
Higher levels of blood conjugated bilirubin might be due to severe
damage to the liver cells and enzymes, as a result of reduced number of
viable hepatocytes [54]. In Table 3, there is a general increase in the
total cholesterol at the sub-chronic stage, excluding the HDL levels
which decreases drastically among the medium and high dosed groups.
The decrease in the HDL levels in the medium to high dose rats signifies
that the liver might be impaired and hence produces it in low quantities
(Table 3). Similarly, VLDL which is tagged as bad cholesterol reduced
successively in low to high dosage groups. High VLDL cholesterol level
has been reported to be connected with peril of cardiovascular disease
and stroke. Mostly, VLDL cholesterol level is often not targeted for high
blood cholesterol treatment, but rather therapeutic remedy target LDL
cholesterol level [55,56]. However, any drug that may target both LDL
and VLDL will be a good therapy for dealing with high cholesterol levels
in the blood.
Similarly, liver enzymes increased across the different doses ad-
ministered except ALT which appears to decrease in the high dose ad-
ministered rats in respect of the control group (Table 3). This result
might indicate severe damage to the liver as a result of depletion of ALT
levels in the liver. The resolution above agrees with Al-seeni et al. who
discovered decline in liver enzymes after tartrazine was administered to
rats [57]. Comparing the levels of AST among the low, medium and
high dose groups administered rats, it could be observed from the re-
sults that, the levels of AST decrease as the dose increases, while the
levels of ALT drastically increased among low and medium dose ad-
ministered rats, except in the high dose rats which recorded decreased
levels (Table 3). Finally, there were increasing levels of unconjugated
bilirubin and decrease levels of conjugated bilirubin among all the
various groups of rats as compared to the control group. This reason
might be as a result of increased rate of red blood cells breakdown;
consequently, there is much unconjugated bilirubin in the blood
waiting to be conjugated by the liver. Again, injured hepatocytes re-
vealed during histopathological analysis, are unable to keep pace with
the processing of the unconjugated bilirubin. This increased amount of
bilirubin in the plasma, accounting for the increasing levels of un-
conjugated bilirubin. The situation could also be attributed to an in-
terrupted regulation of hepatobiliary conveyance systems at the sinu-
soidal and canalicular membrane of hepatocytes by the individual
components of the unripe lime essential oil [58].
3.5. Analysis of hematological parameters
Table 4 depicts the hematological data of the sub-acute studies. The
levels of RBCs increased significantly in all the groups at the sub-acute
stage. The same results can be observed in the medium and high dose
groups at the sub-chronic stage of the study (Table 5) compared to the
control and reference range. The trend of hematological result is at-
tributed to uncontrolled erythropoiesis activities in the bone marrow
due to low oxygen levels, in this case, more RBCs is produced to
compensate for any condition that results in low oxygen levels [59].
Fig. 6. Photomicrographs of lungs sections for
the normal control (A), sub-acute (B–D) and
sub-chronic (E–G) stage. (A) Control: shows
normal alveolar duct with its walls consisting
of adjacent alveoli (blue arrow) separated by
interalveolar septa (black arrow). (B) Low
dose: has normal histology as compared to the
normal control group. (C) Medium dose: mild
leukocytosis (blue arrow) with thickened
aveoli septa (black arrow). (D) High dose:
shows the presence of few inflammatory cells.
(E) Low dose: slightly thickened aveoli septa
(blue arrow), accompanied by focal inter-
aveoli congestion (black arrows) (F) Medium
dose: moderately thickened aveoli septa (blue
arrow) accompanied by mild inter-aveoli con-
gestion (black arrows) (G) High dose: shows
marked leukocytic infiltrate within sections (H
&E×100).
Table 2
Serum biochemical parameters in rats treated orally with unadulterated Lime Essential oil (daily dose) at the sub-acute stage (n= 10).
Biochemical Parameters (+SEM) Determined Dosages (mg/kg bw)
Normal control Low (50) Medium (100) High (500) aReference range
Cholesterol (mmol/L) 1.61 + 0.12 1.58+0.01 ns 1.58+0.01 ns 1.79 +0.01 ns 1.20-2.38
Triglyceride (mmol/L) 0.86+0.01 0.67+0.01 ns 0.62+0.01 ns 0.78+0.01 ns 0.35–1.4
HDL (mg/dL) 22.00+1.16 33.00+0.29*** 33.00+1.16*** 47.00+1.16*** 20.0-23.0
LDL (g/dL) 25.00+0.58 16.00+1.16*** 17.00+0.58*** 18.00+0.57** 23.5-27.5
VLDL (mg/L) 15.00+1.73 12.00+1.16 ns 11.00+0.58 ns 14.00+0.29ns 15.5-20.5
Dir. Bili. (mg/dl) 0.01+ 0.00 0.12+0.01 ns 0.15+0.01 ns 0.26+0.01 ns 0.05-0.10
Indir. Bil (mg/dL) 0.75+ 0.03 0.72+0.06 ns 0.71+0.01 ns 0.48+0.01ns 0.74-0.80
AST (μ/L) 12.50+0.29 190.0+0.58*** 175.00+2.89*** 435.00+1.16*** 39.0-111
ALT (μ/L) 66.00+0.58 100.00+5.77*** 434.00+1.16*** 118.00+0.58*** 20.0-61.0
ALP (μ/L) 354.00+0.58 624.00+0.58*** 282.00+1.16*** 524.00+0.58*** 39.0-216.0
Abbreviations: AST = aspartate aminotransferase, ALT = alanine aminotransferase, ALP = Alkaline Phosphatase Level, HDL= High density lipoprotein, LDL = Low
density lipoprotein, VLDL= very low-density lipoprotein. Note: Significant difference between Control group and Experimental group: ns implies non-significant
difference; (*) = P<0.05, (**) = P=<0.01, and (***) = P< 0.001[63]a.
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This also reflects a corresponding increase in the hematocrit levels since
hematocrit determines the percentage of RBCs in blood by volume that
is composed of RBCs. Surprisingly, the levels of RBC from the low dose
group at the sub-chronic stage (Table 5) were normal. Hemoglobin le-
vels decreased in all groups but highly significant (p < 0.001) among
the medium (100 mg/kg) dosed groups (both sub-acute and sub-chronic
stage). The decreased levels of hemoglobin might have resulted from
the inability to utilize iron to make hemoglobin, as a result there was a
decreased level of MCV due to small average RBCs size which might be
a deficiency of iron, and this phenomenon is supported by mild to
moderate hemosiderin deposit within the spleen of these groups. This
has been reported in previous studies [48].
In Table 4 (all dose groups) and Table 5 (medium and high dose
groups), it can also be observed that the levels of MCH, MCHC, and
MCV reduced significantly (p < 0.001) among all the various dose
groups compensating the smaller RBCs size due to low levels of he-
moglobin found in each cell, while the corresponding increase in the
sub-chronic stage of low dose group might result from the normal levels
of the RBCs. The platelet and lymphocyte levels increased drastically
(p < 0.001) in both sub-acute and sub-chronic stages (Tables 4 and 5),
except in the high dose group which appears to show a decreased level.
This might be as a result of inflammation in the liver leading to bone
marrow production of more platelets and lymphocytes to heal wounds
and fight against etiological agents respectively, as reported earlier
Table 3
Serum biochemical parameters in rats treated orally with unadulterated Lime Essential oil (daily dose) at the sub-chronic stage (standard error of the mean=SEM)
(n=10).
Biochemical Data Determined Dosages (mg/kg/bw)
Normal control Low (50) Medium (100) High (500) bReference range
Cholesterol (mmol/L) 1.17+0.01 1.61+0.01 ns 1.42+0.01 ns 1.37+0.01 ns 1.10-1.20
Triglyceride (mmol/L) 0.41+ 0.01 0.78+0.01 ns 0.66+ 0.01 ns 0.88+0.02 ns 0.35-0.45
HDL (mg/Dl) 27.00+0.58 45.0+0.58*** 18.00+0.58 *** 14.00+0.58*** 20.0-30.0
LDL (g/Dl) 11.00+0.58 3.00+0.05*** 25.00+0.29*** 23.00+0.58*** 10.0-15.0
VLDL (mg/L) 7.00+ 0.58 14.0+0.58*** 12.0+0.06*** 16.00+0.58*** 5.0-10.0
Dir. Bil. (mg/dl) 0.16+0.02 0.10+0.29 ns 0.14+0.01 ns 0.13+0.01 ns 0.15-0.20
Indir. Bil. (mg/dl) 0.27+ 0.01 0.73+0.01 ns 0.67+0.01 ns 0.73+0.02 ns 0.20-0.30
AST (μ/L) 120.00+2.89 319.0+0.58*** 159.0+0.58*** 124.0+1.16 ** 100-130.0
ALT(μ//L) 96.00 +0.58 107.0+1.15*** 434.00+0.58*** 80.0+0.58*** 90.0-100.0
ALP (μ//L) 669.00+0.58 584.0+1.73*** 933.00+0.58*** 668.0+0.58 ns 600-700.0
Note: Significant difference between Control group and Experimental group: ns implies non-significant difference; (*) = P < 0.05, (**) = P=<0.01, and (***) =
P< 0.001 [64]b.
Table 4
Hematological parameters in rats treated orally with unadulterated Lime Essential oil at sub-acute (+SEM) (n= 10).
Hematological Parameters Determined Dosages (mg/kg BW)
Normal control Low(50) Medium (100) High (500) cReference range
RBCs (M/u) 3.97+ 0.01 6.68+0.02*** 6.95+0.01*** 7.55+0.03*** 4.3–6.46
Hematocrit (%) 33.80+0.06 38.70+0.06*** 38.10+0.06*** 39.80+0.12 *** 39–47
MCV (fL) 85.30+0.06 57.90+0.26*** 55.90+0.29*** 52.70+0.12*** 70–88
Hemoglobin(g/dL) 13.60+0.17 12.80+0.12 ns 7.70+0.12*** 13.30+0.06 ns 12.3–17.5
MCH (pg) 34.20+0.12 19.30+0.12*** 19.50 +0.06*** 17.60+0.06*** 25-31
MCHC (g/dL) 40.20+0.12 33.30+0.17*** 34.8+0.06*** 33.40+0.23*** 32-39
Platelet (105/μL) 6.13+0.56 7.52+ 1.16*** 6.32+1.16*** 9.67+0.58*** 8.00–9.00
Lymphocytes (%) 35.20+0.06 75.50+0.29*** 66.00+0.29*** 79.50+0.29*** 63–93
MID (%) 15.90+0.12 2.70+ 0.06*** 1.10+0.06*** 0.80+0.03*** 13.0-16.0
RBC= red blood cells, MCV=mean corpuscular volume, MCH=mean corpuscular hemoglobin, MCHC=mean corpuscular hemoglobin concentration,
MID=multi-infarct dementia. Note: Significant difference between Control group and Experimental group: ns implies non-significant difference; (*) = P < 0.05,
(**) = P=<0.01, and (***) = P< 0.001 [65,66]c.
Table 5
Hematological parameters in rats treated orally with unadulterated Lime Essential oil at the sub-chronic stage (+SEM) (n= 10).
Hematological Parameters Determined Dosages (mg/kg bw)
Normal control Low (30) Medium (100) High (500) dReference rage
RBCs (M/u) 3.97+0.01 3.83+0.01 ns 4.94+0.01 ns 5.25+0.03 ns 4.3–6.46
Hematocrit (%) 33.80+0.35 15.80+0.12*** 40.80+0.06*** 34.80+0.12 ns 39–47
MCV (fL) 85.30+0.06 91.80+0.58*** 82.70+0.06 ** 66.40+0.058*** 70–88
Hemoglobin(g/dL) 13.60+0.06 10.00 + 0.58*** 10.00+0.12*** 12.70+0.058 ns 12.3–17.5
MCH (pg) 34.20+0.12 57.80+0.17*** 20.20+0.12*** 24.10+0.06*** 25-31
MCHC (g/dL) 40.20+0.12 63.20+0.06*** 24.50+0.29*** 36.40+0.23*** 32-39
Platelet 613.00+1.73 1034+0.58*** 791.00+0.58** 139.00+1.16*** 8.00–9.00
Lymphocytes (%) 35.20+0.06 41.90+0.06*** – 46.40+0.23*** 63–93
MID (%) 15.90+0.23 15.60+0.12 ns – 3.00+0.289*** 13.0-16.0
Note: Significant difference between Control group and Experimental group: ns implies non-significant difference; (*) = P < 0.05, (**) = P=<0.01, and (***) =
P< 0.001. [65,66]d.
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[60,61]. While the decrease levels of the platelets in sub-chronic high
dose group might be due to damage to the liver, it reduces the levels of
globulin produced to assist in blood clotting [62]. The inflammation in
the liver is also confirmed by the decrease levels of MID at the sub-acute
stage (Table 4) and also by histopathology studies (Fig. 4).
4. Conclusion
On the whole, it seems the consumption of lime essential oil leads to
cellular injury (necrosis) and trigger inflammatory response in tissues.
These effects are strongly attributed to β-pinene, trans-anethole, ger-
macrene D and linalool which are the main components of the oil
identified by GC/MS. The present results means continuous exposure to
the oil could lead to organ malfunction. However, the oil does not seem
to elicit any signs of acute toxicity or to have any significant effect on
weight. From the results obtained, it is safe to conclude that the oil has
some form of toxic effects on some of the vital organs at the sub-chronic
stage. Considering the pathological effects seen in the various tissues
and the fact that these effects became more severe as the dosage and
time of exposure to the oil increased, further work will be crucial to
explain this concept. From the results, it is recommended that me-
chanistic tests be carried out to determine exactly how the oil causes the
changes seen in the organs. Other routes of administration should be
considered since the oil is used in a lot of ways.
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